The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells

Published:2011-06-23 Issue:14 Volume:585 Page:2331-2338
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Yoon Chang-Hwan,Hyun Kyung-Hwan,Kim Rae-Kwon,Lee Hyejin,Lim Eun-Jung,Chung Hee-Yong,An Sungkwan,Park Myung-Jin,Suh Yongjoon,Kim Min-Jung,Lee Su-Jae

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference37 articles.

1. Cancer stem cells and human malignant melanoma;Schatton;Pigment Cell Melanoma Res.,2008

2. Cancer stem cells in nervous system tumors;Singh;Oncogene,2004

3. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor;Bao;Cancer Res.,2006

4. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance;Zhou;Proc. Natl. Acad. Sci. USA,2007

5. Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions;Inagaki;Biochem. Biophys. Res. Commun.,2007

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1;Cancer Research Communications;2024-06-25

2. Stem cells and therapy: cancer stem cells and targeted therapy with DNA repair inhibitors;Stem Cells and Signaling Pathways;2024

3. Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1;2023-07-25

4. Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models;Cancers;2022-09-30

5. DNMT3A/miR-129-2-5p/Rac1 Is an Effector Pathway for SNHG1 to Drive Stem-Cell-like and Invasive Behaviors of Advanced Bladder Cancer Cells;Cancers;2022-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3